By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – NanoString Technologies today said that it has raised $20 million in a Series D round of financing.

Among the new investors in the firm is GE, through its healthymagination Fund, as well as former Genzyme Chairman and CEO Henri Termeer. All previous investors in the firm, including Clarus Ventures, Draper Fisher Jurvetson, and OVP Venture Partners, also participated in the financing round.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: dynamics of protein profusion and localization, melanoma classification schemes, and more.

A company says it can generate likenesses of people based on their genetic profiles.

IBM's Watson is learning how to treat leukemia as a fellow at the MD Anderson Cancer Center, according to the Washington Post.

In PNAS this week: ancestry and admixture in Brazilians, characterization of novel double-stranded RNA mycovirus, and more.